Research programme: vanilloid receptor antagonists - Novartis
Alternative Names: TRPV1 antagonists- Novartis; TRVPV-1 antagonists - Novartis; VR-1 antagonists - NovartisLatest Information Update: 16 Jul 2010
At a glance
- Originator Novartis
- Class
- Mechanism of Action TRPV cation channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 16 Jul 2010 Discontinued - Preclinical for Neuropathic pain in Switzerland (PO)
- 16 Jul 2010 Discontinued - Preclinical for Neuropathic pain in United Kingdom (PO)
- 27 Jun 2006 Preclinical trials in Neuropathic pain in Switzerland (PO)